TILS.L Regulatory News (TILS)

28 Nov 2008 16:24



Immediate Release

28 November 2008

ReGen Therapeutics Plc

('ReGen' or the Company')

Total Voting Rights

For the purposes of the Disclosure and Transparency Rules of the Financial Services Authority, the Board of ReGen is required to notify the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 14,207,050 ordinary shares with a nominal value of 10 p each, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury.

Therefore the total number of Ordinary Shares in the Company with voting rights is 14,207,050.

The above figure of 14,207,050 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules.

Please note that following an issue of equity announced on 25 November 2008, an additional 350,000 new Ordinary Shares will be admitted to trading on AIM on 1 December 2008. Subsequent to the issue of these new shares, from 1 December 2008, the Company will have 14,557,050 Ordinary Shares in issue and this figure should be then used by shareholders in the Company as the denominator.

ENDS

For further information, please contact:

Percy Lomax

ReGen Therapeutics Plc

Tel: 020 7153 4920

Roland Cornish/Felicity Geidt

Beaumont Cornish Limited

Tel: 020 7628 3396

David Scott/Nick Bealer

Alexander David Securities Limited

Tel: 020 7448 9800